Terming the stories as “completely misleading, fallacious and ill-informed”, the Centre mentioned the nationwide regulator CDSCO (Central Drugs Standard Control Organisation) adopted a scientific strategy and prescribed norms in approving Covid-19 vaccines for emergency use authorization (EUA).

It additionally identified that CDSCO’s Subject Expert Committee (SEC), which consists of area data specialists, granted restricted emergency approval to Covaxin solely after due deliberations in conferences on January 1 & 2, 2021.